Purchase Order 75D30123P18234
Award Date
9/28/23
Potential Completion Date
9/24/24
Potential Value
$20K
Federal Agency
CDC Pittsburgh
Awardee
Illumina, Inc.
Ultimate Awardee
Not listed
NAICS Category
325413 - In-Vitro Diagnostic Substance Manufacturing
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Not Competed under SAP
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
San Diego, CA 92122, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
1
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a firm fixed-price purchase order awarded by the Centers for Disease Control and Prevention (CDC) to Illumina, Inc., a manufacturer of genomic sequencing and array-based analysis systems. The $42,553.12 contract is for a MiSeq Silver and iSeq 100 service agreement covering the period from September 15, 2022 to September 15, 2023. The award does not have a set-aside designation. Illumina has a history of providing sequencing platforms, reagents, and maintenance services to support genomic...
This is a firm fixed price purchase order contract awarded by the Centers for Disease Control and Prevention (CDC) Pittsburgh office to Illumina, Inc., a manufacturer of genetic sequencing systems and reagents. The contract, valued at $20,400.00, is for the provision of ILLUMINA - AMPLISEQ products and services, with a period of performance through September 30, 2024. The contract has no set-aside designation. Illumina has a history of providing sequencing equipment and consumables to support...
This is a $94,050.00 firm fixed price purchase order awarded by the Centers for Disease Control and Prevention (CDC) to Illumina, Inc., a manufacturer of sequencing and analysis instruments and reagents. The award is for an Illumina MiSeq sequencing system and does not have a set-aside designation. Illumina has a history of providing sequencing equipment and services to support research and diagnostics across various federal agencies, including the National Institutes of Health, Department of...
This is a firm fixed price purchase order contract awarded by the Centers for Disease Control and Prevention (CDC) to Illumina, Inc. for a MiSeq System, sequencing instrument and associated services. The contract has a ceiling value of $97,020.00 and was awarded on April 13, 2022, with a completion date of July 1, 2022. This contract was not set aside for a specific business type. Illumina is a for-profit manufacturer of genomic sequencing and analysis products, and has experience providing...
This is a firm fixed-price purchase order awarded by the Centers for Disease Control and Prevention (CDC) to Illumina, Inc., a manufacturer and provider of sequencing and array-based solutions for genetic and genomic analysis. The contract, valued at $83,870.68, is for preventative maintenance services on Illumina's MiSeq instruments. The period of performance runs from the award date of July 10, 2018, through June 30, 2023. This award does not utilize a set-aside. Illumina has a history of...
This firm fixed-price purchase order was awarded by the Centers for Disease Control and Prevention (CDC) in Pittsburgh to Illumina, Inc., a manufacturer of sequencing and array-based solutions for genetic and genomic analysis. The $20,149 contract is for SUPPORT SERVICES - ISEQ MAINTENANCE, with a period of performance through June 14, 2026. Illumina is a veteran federal contractor, having provided sequencing systems, reagents, and services to support genomic research and diagnostics across...
This is a firm fixed price purchase order awarded by the U.S. Centers for Disease Control and Prevention (CDC) to Illumina, Inc., a manufacturer of genetic sequencing instruments and reagents, for a MiSeq System. The $131,966.00 contract has a period of performance ending on July 31, 2016. Illumina has provided sequencing systems and services to various federal agencies in the past, including the National Institutes of Health, Department of Agriculture, and Department of Veterans Affairs, to...
This $96,401.25 firm fixed price purchase order contract was awarded by the Centers for Disease Control and Prevention (CDC) Pittsburgh facility to Illumina, Inc., a manufacturer of sequencing and array-based genomic analysis products. The contract is for the provision of a MiSeq DNA sequencing system and does not have a set-aside designation. Illumina has previously received prime federal contract awards from agencies like the NIH, USDA, VA, and others for sequencing systems, reagents, and...
This is a firm fixed price purchase order awarded by the Centers for Disease Control and Prevention (CDC) to Illumina, Inc., a for-profit manufacturer of genetic sequencing instruments and reagents. The contract is for the provision of an Illumina MiSeq genomic sequencing system, with a ceiling value of $135,435.37 and a performance period ending on November 30, 2015. The order does not have a set-aside designation. Illumina has previously received prime federal contract awards from agencies...
This is a firm fixed price Blanket Purchase Agreement (BPA) call order awarded to Illumina, Inc., a manufacturer of sequencing instruments and reagents, by the Centers for Disease Control and Prevention (CDC) Pittsburgh. The $67,395.38 award is for an "ILLUMINA PRODUCT CARE PLAN" to provide support and maintenance services for Illumina's NextSeq, NovaSeq, MiSeq, and iSeq sequencing platforms used by the CDC. This award is not associated with a set-aside program. Illumina has a...